Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

NEWTEKONE, INC. (NEWT)

  • Business News
  • June 12, 2026, 12:44 UTC
  • 5
  • 1 comments

NewtekOne, Inc. Declares Dividends on Common Stock and Series B Preferred Shares

Market reaction Comment Full text

CAESARS ENTERTAINMENT, INC. (CZR)

  • Business News
  • June 12, 2026, 12:40 UTC
  • 6
  • 1 comments

A New Jewel on the Las Vegas Strip: Lisa Vanderpump Celebrates Grand Opening of The Vanderpump Hotel

Market reaction Comment Full text

CSOP ASSET MANAGEMENT PTE. LTD. (LCS)

  • Business News
  • June 12, 2026, 12:33 UTC
  • 2
  • 0 comments

General Announcement: Net Asset Value per unit

Market reaction Comment Full text

CSOP ASSET MANAGEMENT PTE. LTD. (LCS)

  • Business News
  • June 12, 2026, 12:33 UTC
  • 2
  • 0 comments

General Announcement: Net Asset Value per unit

Market reaction Comment Full text

CSOP INVESTMENTS III VCC (SUN)

  • Business News
  • June 12, 2026, 12:32 UTC
  • 2
  • 0 comments

General Announcement: Net Asset Value per unit

Market reaction Comment Full text

PEPSICO INC (PEP)

  • Business News
  • June 12, 2026, 12:32 UTC
  • 5
  • 1 comments

Clinical trial NCT07400614 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-08-30 → 2026-07-15 3. primary completion date: 2026-08-30 → 2026-07-15

Market reaction Comment Full text

ASTRAZENECA PLC (AZN)

  • Business News
  • June 12, 2026, 12:32 UTC
  • 4
  • 1 comments

Clinical trial NCT07490860 updates: 1. enrollment: 57 → 45 participants 2. allocation: NON_RANDOMIZED → NA

Market reaction Comment Full text

ASTRAZENECA PLC (AZN)

  • Business News
  • June 12, 2026, 12:32 UTC
  • 6
  • 1 comments

Clinical trial NCT07529860: start date: 2026-04-01 → 2026-07-01.

Market reaction Comment Full text

ARCH BIOPARTNERS INC. (ACHFF)

  • Business News
  • June 12, 2026, 12:32 UTC
  • 6
  • 1 comments

Clinical trial NCT05879432 updates: 1. completion date: 2026-12-01 → 2027-08-01 2. primary completion date: 2026-08-01 → 2027-03-01

Market reaction Comment Full text

H. LUNDBECK A/S (HLBBF)

  • Business News
  • June 12, 2026, 12:32 UTC
  • 8
  • 1 comments

Clinical trial NCT06323928 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-30 → 2026-03-16

Market reaction Comment Full text
  • Previous
  • 2330
  • 2331
  • 2332
  • 2333
  • 2334
  • Next

Search

News categories

  • Technical Exchange News(14061)
  • Event(6229)
  • SEC News(358189)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(216987)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin